Mefenamic Acid Mercury Pharmaceuticals

Mefenamic Acid, the active ingredient in Mefenamic Acid Mercury Pharmaceuticals, is a NSAID (fenamate) presented as an oral tablet for oral use. It is employed to relieve mild to moderate pain, including menstrual cramps, and to reduce inflammation in various conditions, such as arthritis.

GNH USA supplies Mefenamic Acid Mercury Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance, and reliable logistics across global markets. The product complies with EU pharmacopeial standards and is distributed under strict quality control protocols.

Mefenamic Acid is an NSAID that acts on prostaglandin-mediated pain and inflammation pathways. - Mild to moderate pain: provides analgesic relief for conditions such as dental pain, musculoskeletal aches, and postoperative discomfort. - Dysmenorrhea (menstrual pain): reduces uterine cramping and associated discomfort during menstruation. - Inflammatory conditions: alleviates inflammation and swelling in disorders such as osteoarthritis and rheumatoid arthritis.

Mefenamic Acid may cause a range of adverse reactions, varying from frequent mild events to rare serious conditions.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo: transient light‑headedness.

Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding. - Renal impairment or acute kidney injury. - Severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome.

When prescribing Mefenamic Acid, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: evaluate kidney status before initiating therapy, especially in patients with existing renal disease. - Monitor gastrointestinal risk: use caution in individuals with a history of ulcers, bleeding, or NSAID intolerance. - Evaluate hepatic function: check liver enzymes in patients with liver disease or chronic alcohol use. - Use the lowest effective dose: limit duration to the shortest period necessary to control symptoms. - Avoid use in late pregnancy: NSAIDs may affect fetal circulation and prolong labor. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Mefenamic Acid can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal function. - Lithium: NSAIDs may raise lithium serum levels. - Methotrexate: decreased clearance leading to toxicity.